$IVDN
INNOVATIVE DESIGNS INC Stock $ivdn

$ivdn Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000173112224000714 Filed on April 30, 2024

Income Statement

Concept	2024 Q2	2024 Q1
Revenue	$300.3K	$65.89K
YoY Change	1002.13%	-8.04%
Cost Of Revenue	$151.6K	$34.82K
YoY Change	1035.28%	104.7%
Gross Profit	$148.8K	$31.07K
YoY Change	970.29%	-43.13%
Gross Profit Margin	49.54%	47.16%
Selling, General & Admin	$121.0K	$85.68K
YoY Change	-0.67%	-25.27%
% of Gross Profit	81.36%	275.77%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$1.165K	$1.165K
YoY Change	51.3%	51.5%
% of Gross Profit	0.78%	3.75%
Operating Expenses	$121.0K	$120.5K
YoY Change	-0.67%	-8.47%
Operating Profit	$27.73K	-$54.62K
YoY Change	-125.69%	-8.99%
Interest Expense	-$4.340K	$7.608K
YoY Change	-6.26%	15.29%
% of Operating Profit	-15.65%
Other Income/Expense, Net	-$5.503K	-$8.773K
YoY Change		-1053.59%
Pretax Income	$22.23K	-$63.39K
YoY Change	-119.74%	7.28%
Income Tax
% Of Pretax Income
Net Earnings	$22.23K	-$63.39K
YoY Change	-119.74%	7.27%
Net Earnings / Revenue	7.4%	-96.22%
Basic Earnings Per Share	$0.00	$0.00
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	37.92M shares	37.92M shares
Diluted Shares Outstanding	37.46M shares	38.05M shares

Balance Sheet

Concept	2024 Q2	2024 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$241.7K	$208.2K
YoY Change	271.8%	22.87%
Cash & Equivalents	$241.7K	$208.2K
Short-Term Investments
Other Short-Term Assets		$6.400K
YoY Change
Inventory	$523.4K	$601.0K
Prepaid Expenses
Receivables	$123.2K	$10.40K
Other Receivables	$16.54K	$0.00
Total Short-Term Assets	$904.9K	$826.0K
YoY Change	29.84%	0.63%
LONG-TERM ASSETS
Property, Plant & Equipment	$21.15K	$22.31K
YoY Change	-15.47%	-13.46%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$652.9K	$666.1K
YoY Change	-1.09%	7.34%
Total Long-Term Assets	$674.1K	$688.5K
YoY Change	-1.62%	6.51%
TOTAL ASSETS
Total Short-Term Assets	$904.9K	$826.0K
Total Long-Term Assets	$674.1K	$688.5K
Total Assets	$1.579M	$1.514M
YoY Change	14.25%	3.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$60.65K	$84.72K
YoY Change	-71.23%	-51.91%
Accrued Expenses		$35.24K
YoY Change		832.77%
Deferred Revenue
YoY Change
Short-Term Debt	$72.32K	$12.00K
YoY Change	-9.23%	-87.56%
Long-Term Debt Due		$70.53K
YoY Change		247.27%
Total Short-Term Liabilities	$231.8K	$202.5K
YoY Change	-38.99%	-41.76%
LONG-TERM LIABILITIES
Long-Term Debt	$42.36K	$39.38K
YoY Change	-22.7%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$42.36K	$39.38K
YoY Change	-22.7%	-33.86%
TOTAL LIABILITIES
Total Short-Term Liabilities	$231.8K	$202.5K
Total Long-Term Liabilities	$42.36K	$39.38K
Total Liabilities	$274.2K	$241.9K
YoY Change	-36.93%	-40.6%
SHAREHOLDERS EQUITY
Retained Earnings	-$10.64M	-$10.70M
YoY Change	1.23%	2.94%
Common Stock	$11.98M	$11.97M
YoY Change	4.61%	4.52%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.305M	$1.273M
YoY Change
Total Liabilities & Shareholders Equity	$1.579M	$1.514M
YoY Change	14.25%	3.22%

Cashflow Statement

Concept	2024 Q2	2024 Q1
OPERATING ACTIVITIES
Net Income	$22.23K	-$63.39K
YoY Change	-119.74%	7.27%
Depreciation, Depletion And Amortization	$1.165K	$1.165K
YoY Change	51.3%	51.5%
Cash From Operating Activities	-$97.36K	-$102.9K
YoY Change	126.84%	-2.18%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	$0.00
YoY Change	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	130.9K	$92.34K
YoY Change	-698.31%	279.48%
NET CHANGE
Cash From Operating Activities	-97.36K	-$102.9K
Cash From Investing Activities	0.000
Cash From Financing Activities	130.9K	$92.34K
Net Change In Cash	33.55K	-$10.52K
YoY Change	-132.14%	-88.79%
FREE CASH FLOW
Cash From Operating Activities	-$97.36K	-$102.9K
Capital Expenditures
Free Cash Flow		-$102.9K
YoY Change		-18.2%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	ivdn	Deposits On Inventory DepositsOnInventory		usd
CY2024Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent		usd
CY2023Q1	us-gaap	Payments To Employees PaymentsToEmployees		usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		usd
CY2024Q1	us-gaap	Payments For Other Deposits PaymentsForOtherDeposits		usd
CY2023Q1	us-gaap	Payments For Other Deposits PaymentsForOtherDeposits		usd
CY2024Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities		usd
CY2023Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
CY2024Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Pittsburgh
CY2024Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	PA
CY2024Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	15223
CY2024Q1	dei	City Area Code CityAreaCode	412
CY2024Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
CY2024Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2024Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q1	dei	Entity Shell Company EntityShellCompany	false
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	37924003	shares
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208153	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	238677	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10397	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31050	usd
CY2024Q1	us-gaap	Inventory Net InventoryNet	601027	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	549277	usd
CY2024Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6400	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	0	usd
CY2024Q1	us-gaap	Assets Current AssetsCurrent	825977	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	819004	usd
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22314	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	23479	usd
CY2024Q1	ivdn	Deposits On Inventory DepositsOnInventory	20000	usd
CY2024Q1	ivdn	Advance To Employee Noncurrent AdvanceToEmployeeNoncurrent	13200	usd
CY2023Q4	ivdn	Advance To Employee Noncurrent AdvanceToEmployeeNoncurrent	8200	usd
CY2024Q1	us-gaap	Deposits On Flight Equipment DepositsOnFlightEquipment	652944	usd
CY2023Q4	us-gaap	Deposits On Flight Equipment DepositsOnFlightEquipment	652944	usd
CY2024Q1	us-gaap	Other Assets OtherAssets	666144	usd
CY2023Q4	us-gaap	Other Assets OtherAssets	661144	usd
CY2024Q1	us-gaap	Assets Assets	1514435	usd
CY2023Q4	us-gaap	Assets Assets	1503627	usd
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	84720	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	216626	usd
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	70530	usd
CY2023Q4	us-gaap	Notes Payable Current NotesPayableCurrent	20397	usd
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	35244	usd
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	42873	usd
CY2024Q1	ivdn	Current Portion Of Stockholder Loans CurrentPortionOfStockholderLoans	12000	usd
CY2023Q4	ivdn	Current Portion Of Stockholder Loans CurrentPortionOfStockholderLoans	70668	usd
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	202494	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	350564	usd
CY2024Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	39380	usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	44429	usd
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	39380	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	44429	usd
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	25000000	shares
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100800000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100800000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37783448	shares
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37783448	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	34650560	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	34650560	shares
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	3781	usd
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	3656	usd
CY2024Q1	ivdn	Common Stock To Be Issued CommonStockToBeIssued	0	usd
CY2023Q4	ivdn	Common Stock To Be Issued CommonStockToBeIssued	0	usd
CY2024Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	11969130	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	11741935	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10700350	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10636957	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1272561	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1108634	usd
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1514435	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1503627	usd
CY2024Q1	us-gaap	Revenues Revenues	65886	usd
CY2023Q1	us-gaap	Revenues Revenues	71647	usd
CY2024Q1	ivdn	Cost Of Revenues CostOfRevenues	34824	usd
CY2023Q1	ivdn	Cost Of Revenues CostOfRevenues	17010	usd
CY2024Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	85682	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	113882	usd
CY2024Q1	us-gaap	Operating Expenses OperatingExpenses	120506	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	130892	usd
CY2024Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-54620	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-59245	usd
CY2024Q1	ivdn	Miscellaneous Income Expense MiscellaneousIncomeExpense	0	usd
CY2023Q1	ivdn	Miscellaneous Income Expense MiscellaneousIncomeExpense	7519	usd
CY2024Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	58668	usd
CY2023Q1	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	80840	usd
CY2024Q1	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	50000	usd
CY2024Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	4916	usd
CY2023Q1	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	4828	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	7608	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	6599	usd
CY2024Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-8773	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	151	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-63393	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-59094	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.002
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37092277	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34914060	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.002
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	38046277	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	35908060	shares
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	1108634	usd
CY2024Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	105920	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	121400	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	-63393	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	1272561	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	110000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	5940	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-59094	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	1059918	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-63393	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-59094	usd
CY2024Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	121400	usd
CY2023Q1	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	5940	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1165	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	769	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	7519	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-20653	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-3136	usd
CY2024Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	31750	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	147124	usd
CY2024Q1	us-gaap	Increase Decrease In Prepaid Rent IncreaseDecreaseInPrepaidRent	6400	usd
CY2024Q1	ivdn	Increase Decrease In Deposits On Inventories IncreaseDecreaseInDepositsOnInventories	-20000	usd
CY2023Q1	ivdn	Increase Decrease In Deposits On Inventories IncreaseDecreaseInDepositsOnInventories	80000	usd
CY2024Q1	us-gaap	Payments To Employees PaymentsToEmployees	5000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-131906	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	14089	usd
CY2024Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-7629	usd
CY2023Q1	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	4647	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-102860	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-105156	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20593	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	7519	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-13074	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	105920	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	110000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	92336	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24332	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-30524	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-93898	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	238677	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	263293	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	208153	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	169395	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	15237	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1952	usd
CY2024Q1	ivdn	Noncash Financing Activities Common Stock Issued For Services NoncashFinancingActivitiesCommonStockIssuedForServices	121400	usd
CY2023Q1	ivdn	Noncash Financing Activities Common Stock Issued For Services NoncashFinancingActivitiesCommonStockIssuedForServices	5940	usd
CY2024Q1	us-gaap	Basis Of Accounting BasisOfAccounting	<p id="xdx_807_eus-gaap--BasisOfAccounting_zpZfaMLckbj5" style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-right: 166.95pt; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"> <tr style="vertical-align: top"> <td style="width: 10.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="width: 17.95pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; letter-spacing: -0.05pt"><b>1.</b></span></td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> <span style="letter-spacing: -0.2pt"><span id="xdx_82D_zqHqJXNQF7Ze">BASIS OF PRESENTATION</span></span></b></span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.4pt; text-indent: -18pt"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 7.45pt 0 28.4pt; text-align: justify">In the opinion of management, the accompanying unaudited financial statements contain all adjustments necessary to present fairly Innovative Designs, Inc.’s (the “Company”) financial position as of January 31, 2024, the changes therein for the three month periods then ended and the results of operations for the three month periods ended January 31, 2024 and 2023.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 7.45pt 0 28.4pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 7.05pt 0 28.4pt; text-align: justify">The condensed financial statements included in the Form 10-Q (the “Form”) are presented in accordance with the requirements of the Form and do not include all of the disclosures required by accounting principles generally accepted in the United States of America. For additional information, reference is made to the Company’s annual report on Form <span style="letter-spacing: 0.05pt">10-K </span>for the fiscal year ended October 31, 2023. The results of operations for the three month periods ended January 31, 2024 and 2023 are not necessarily indicative of operating results for the full <span style="letter-spacing: -0.15pt">year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 7.05pt 0 28.4pt; text-align: justify"><span style="letter-spacing: -0.15pt"> </span></p>
CY2024Q1	us-gaap	Profit Loss ProfitLoss	-63393	usd
CY2024Q1	ivdn	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effects CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffects	-102860	usd
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10700350	usd
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31050	usd
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10397	usd
CY2024Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	65600	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	65600	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	50000	usd
CY2023Q4	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.060	pure
CY2023Q4	us-gaap	Secured Debt SecuredDebt	100000	usd
CY2023Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	0.20
CY2024Q1	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	47244	usd
CY2023Q1	us-gaap	Debt Instrument Increase Accrued Interest DebtInstrumentIncreaseAccruedInterest	147450	usd
CY2024Q1	us-gaap	Short Term Debt Percentage Bearing Fixed Interest Rate ShortTermDebtPercentageBearingFixedInterestRate	0.10	pure
CY2023Q1	us-gaap	Short Term Debt Percentage Bearing Fixed Interest Rate ShortTermDebtPercentageBearingFixedInterestRate	0.12	pure
CY2024Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	954000	shares
CY2023Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	994000	shares
CY2024Q1	ivdn	Shipping And Handling Costs ShippingAndHandlingCosts	10899	usd
CY2023Q1	ivdn	Shipping And Handling Costs ShippingAndHandlingCosts	15125	usd
CY2024Q1	ivdn	Deposits On Equipments DepositsOnEquipments	652944	usd
CY2023Q1	ivdn	Deposits On Equipments DepositsOnEquipments	607370	usd
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0550	pure
CY2024Q1	ivdn	Lease Rou Description LeaseROUDescription	The Company entered into a lease for office space at the time the Company was formed through June 2022. Effective July 2022, the Company is leasing the office space on a month to month basis.
CY2024Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	65886	usd
CY2023Q1	us-gaap	Revenue Not From Contract With Customer RevenueNotFromContractWithCustomer	71647	usd
CY2024Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1514435	usd
CY2023Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	1467145	usd
CY2024Q1	us-gaap	Depreciation Depreciation	1165	usd
CY2023Q1	us-gaap	Depreciation Depreciation	769	usd
CY2022Q2	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	260000	usd
CY2024Q1	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001731122-24-000714-index-headers.html	Edgar Link	pending
0001731122-24-000714-index.html	Edgar Link	pending
0001731122-24-000714.txt	Edgar Link	pending
0001731122-24-000714-xbrl.zip	Edgar Link	pending
e5633_10q.htm	Edgar Link	pending
e5633_ex10.htm	Edgar Link	pending
e5633_ex31-1.htm	Edgar Link	pending
e5633_ex31-2.htm	Edgar Link	pending
e5633_ex32-1.htm	Edgar Link	pending
e5633_10q_htm.xml	Edgar Link	completed
e5633_ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
ivdn-20240131.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
ivdn-20240131_def.xml	Edgar Link	unprocessable
ivdn-20240131_lab.xml	Edgar Link	unprocessable
ivdn-20240131_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ivdn-20240131_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$IVDN
INNOVATIVE DESIGNS INC Stock $ivdn

2024 Q2 Form 10-Q Financial Statement

#000173112224000714 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVDN INNOVATIVE DESIGNS INC Stock $ivdn

2024 Q2 Form 10-Q Financial Statement

#000173112224000714 Filed on April 30, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$IVDN
INNOVATIVE DESIGNS INC Stock $ivdn